Inside cells, protein factories called ribosomes have a unique way of patching oxidative stress damage, according to a new discovery from the Karbstein lab.
From his lab and offices in Jupiter, Joe G.N. “Skip” Garcia, M.D. is helping advance clinical translational efforts at UF Health and The Wertheim UF Scripps Institute. He discusses his life's work and vision for the future.
A common amino acid, glycine, delivers the signal to a recently discovered brain receptor linked to depression and anxiety, scientists have found. The discovery appears in the journal Science.
The news and current events can affect us all differently. It's OK to take a break sometimes.
A bioresponsive sensor from Carroll lab activates antioxidants only when needed and provides a tool for studying free radicals' role in disease.
Glioblastoma is fast-moving, and the most common type of brain cancer. Two specific cancer cell mutations may work together to help hide these tumors from the immune system, a study from Janiszewska finds.
TB is again the world's deadliest infectious disease. Luiz Pedro Carvalho, Ph.D., has joined The Wertheim UF Scripps Institute to develop new therapeutics and better understand the germ.
A team led by chemistry professor Ben Shen, Ph.D., discovered a potent anti-cancer compound within the institute's natural products collection. It has been connected to a precise cancer-seeking antibody with an innovative linker molecule.
Matthew Disney, Ph.D. has been named the first Institute Professor of The Wertheim UF Scripps Institute. Disney invented a search-and-destroy system for incurable diseases that targets RNA.
“We show for the first time that you can make brain-penetrant molecules that eliminate toxic gene products,” Disney said.